VHCP Management EG, LLC bought $1.5M of KalVista Pharmaceuticals (KALV)

Executed Feb 12 2025, disclosed Feb 14 2025, 2 days later.

Value, as filed

$1.5M

161,700 sh across 2 lots

Executed

Feb 12 2025

the trade date, as filed

Disclosed

Feb 14 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

VL VHCP Management EG, LLC 10% owner profile →

VHCP Management EG, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in KALV. The largest single filing was $1.5M of KALV (161,700 sh across 2 lots, as filed), executed Feb 12 2025. The median gap between execution and disclosure was 2 days.

The name

KALV KALV KALV · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→